LLY

1,050.93

+2.96%↑

JNJ

248.43

+2.06%↑

ABBV

231.99

+3.33%↑

NVS

168.32

+1.89%↑

MRK

123.72

+3.77%↑

LLY

1,050.93

+2.96%↑

JNJ

248.43

+2.06%↑

ABBV

231.99

+3.33%↑

NVS

168.32

+1.89%↑

MRK

123.72

+3.77%↑

LLY

1,050.93

+2.96%↑

JNJ

248.43

+2.06%↑

ABBV

231.99

+3.33%↑

NVS

168.32

+1.89%↑

MRK

123.72

+3.77%↑

LLY

1,050.93

+2.96%↑

JNJ

248.43

+2.06%↑

ABBV

231.99

+3.33%↑

NVS

168.32

+1.89%↑

MRK

123.72

+3.77%↑

LLY

1,050.93

+2.96%↑

JNJ

248.43

+2.06%↑

ABBV

231.99

+3.33%↑

NVS

168.32

+1.89%↑

MRK

123.72

+3.77%↑

Search

Cytek Biosciences Inc

Закрыт

СекторЗдравоохранение

4.48 2.28

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

4.15

Макс.

4.55

Ключевые показатели

By Trading Economics

Доход

105K

-5.5M

Продажи

6.7M

52M

Прибыль на акцию

-0

Рентабельность продаж

-10.476

Сотрудники

692

EBITDA

6.4M

-4.2M

Рекомендации

By TipRanks

Рекомендации

Покупка

Прогноз на 12 месяцев

+40.23% upside

Дивиденды

By Dow Jones

Следующий отчет о доходах

7 мая 2026 г.

Рыночная статистика

By TradingEconomics

Рыночная капитализация

60M

561M

Предыдущая цена открытия

2.2

Предыдущая цена закрытия

4.48

Новостные настроения

By Acuity

50%

50%

149 / 352 Рейтинг в Healthcare

Техническая оценка

By Trading Central

Уверенность

Weak Bullish Evidence

Cytek Biosciences Inc График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

27 февр. 2026 г., 23:53 UTC

Популярные акции

Stocks to Watch: Aardvark Therapeutics, Blue Moon Metals

27 февр. 2026 г., 22:23 UTC

Приобретения, слияния, поглощения

Blue Moon Metals To Acquire Apex Germanium Mine From Teck Subsidiary

27 февр. 2026 г., 17:55 UTC

Популярные акции

Toronto Stocks Decline, But Remain On Track for Weekly Gains

27 февр. 2026 г., 23:46 UTC

Приобретения, слияния, поглощения

Netflix Walks Away a Winner After Losing Warner Bros. to Paramount -- Barrons.com

27 февр. 2026 г., 23:33 UTC

Приобретения, слияния, поглощения

Paramount Issuing $47 Billion of Equity at Nearly 20% Premium to Current Stock Price -- Barrons.com

27 февр. 2026 г., 21:50 UTC

Обсуждения рынка
Приобретения, слияния, поглощения

Tech, Media & Telecom Roundup: Market Talk

27 февр. 2026 г., 21:50 UTC

Обсуждения рынка

Basic Materials Roundup: Market Talk

27 февр. 2026 г., 21:30 UTC

Отчет

Solventum Beat Wall Street Earnings Estimates. The Stock Falls. -- Barrons.com

27 февр. 2026 г., 21:30 UTC

Обсуждения рынка
Приобретения, слияния, поглощения

Warner Terminates Netflix Deal, Ending Monthslong Saga -- Market Talk

27 февр. 2026 г., 21:20 UTC

Приобретения, слияния, поглощения

Blue Moon Metals to Buy Apex Germanium and Gallium Mine From Teck >BMM

27 февр. 2026 г., 21:17 UTC

Отчет

These Stocks Are Today's Movers: Netflix, Paramount, Block, Sunrun, Dell, Rocket Lab, Nvidia, CoreWeave, and More -- Barrons.com

27 февр. 2026 г., 21:10 UTC

Приобретения, слияния, поглощения

Blue Moon Metals Evaluating Options for a New Processing Line at Springer Complex to Process the Apex Material

27 февр. 2026 г., 21:09 UTC

Приобретения, слияния, поглощения

Blue Moon Metals to Acquire the Apex Germanium and Gallium Mine From Teck

27 февр. 2026 г., 21:00 UTC

Отчет

Nike: 3Q Results to Be Released March 31 to Accommodate for Several Holidays >NKE

27 февр. 2026 г., 20:31 UTC

Приобретения, слияния, поглощения

Netflix Receives $2.8B Termination Fee Under Terminated Warner Bros. Discovery Deal

27 февр. 2026 г., 20:24 UTC

Обсуждения рынка

Oil Gains on Increased Risk of U.S.-Iran Conflict -- Market Talk

27 февр. 2026 г., 20:23 UTC

Обсуждения рынка

U.S. Natural Gas Futures Post Modest Gains -- Market Talk

27 февр. 2026 г., 20:12 UTC

Обсуждения рынка

Nike Seen With Further Challenges in China -- Market Talk

27 февр. 2026 г., 19:44 UTC

Обсуждения рынка

Gold Caps Historic Month -- Market Talk

27 февр. 2026 г., 19:39 UTC

Отчет

These Stocks Are Today's Movers: Netflix, Paramount, Block, Sunrun, Dell, Rocket Lab, Nvidia, CoreWeave, and More -- Barrons.com

27 февр. 2026 г., 19:38 UTC

Отчет

Earnings Could Push the Stock Market Higher. Too Bad About Everything Else. -- Barrons.com

27 февр. 2026 г., 18:53 UTC

Приобретения, слияния, поглощения

Largest U.S. Pension Takes Stake in a Hot Semi Stock, Buys More Nvidia and IonQ -- Barrons.com

27 февр. 2026 г., 18:45 UTC

Отчет

Quantum Computing Is No Longer a Speculative Bet. IonQ's Surging Stock Drives Home That Point. -- Barrons.com

27 февр. 2026 г., 18:45 UTC

Обсуждения рынка

Bitcoin Stays Vulnerable in Choppy Geopolitical Situation -- Market Talk

27 февр. 2026 г., 17:20 UTC

Обсуждения рынка

Basic Materials Roundup: Market Talk

27 февр. 2026 г., 17:07 UTC

Отчет

Pemex Cuts 4Q Loss As Operating Results Improve

27 февр. 2026 г., 17:00 UTC

Обсуждения рынка

Corn Rides Oil Momentum Higher -- Market Talk

27 февр. 2026 г., 16:31 UTC

Обсуждения рынка

Canadian Economy Shows Resilience -- Market Talk

27 февр. 2026 г., 16:17 UTC

Обсуждения рынка

Canada Economy is Struggling But More Rate Cuts Still a Long Shot -- Market Talk

27 февр. 2026 г., 15:49 UTC

Отчет

Quantum Computing No Longer a Speculative Bet. IonQ's Surging Stock Drives Home That Point. -- Barrons.com

Сравнение c конкурентами

Изменение цены

Cytek Biosciences Inc Прогноз

Целевая цена

By TipRanks

40.23% рост

Прогноз на 12 месяцев

Средняя 6.17 USD  40.23%

Максимум 7.5 USD

Минимум 5 USD

Основано на мнении 3 аналитиков Wall Street, спрогнозировавших целевые цены для Cytek Biosciences Inc на следующие 12 месяцев – Данные за последние 3 месяца.

Консенсус по рейтингу

By TipRanks

Покупка

3 ratings

1

Покупка

2

Удержание

0

Продажа

Техническая оценка

By Trading Central

3.7 / 3.8Поддержка и Сопротивление

Краткосрочная

Weak Bullish Evidence

Среднесрочная

Bearish Evidence

Долгосрочная

Bearish Evidence

Настроения

By Acuity

149 / 352Рейтинг в Здравоохранение

Новостные настроения

Neutral

Волатильность

Ниже среднего

Объем новостей (RCV)

Средняя

Финансовые показатели

Расходы на продажи и администрирование

Операционные расходы

Прибыль до уплаты налогов

Продажи

Себестоимость реализации

Валовая прибыль от продаж

Процентные расходы по долгу

EBITDA

Операционная прибыль

$

О компании Cytek Biosciences Inc

Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells; and aurora cell sorter system that leverages full spectrum profiling technology to further broaden potential applications across cell analysis; aurora CS systems; amnis imagestream imaging flow cytometers; guava muse cell analyzers; guava easycyte flow cytometers; and orion reagent cocktail preparation systems. The company also provides reagents and kits, including cFluor reagents that are fluorochrome conjugated antibodies used to identify cells of interest for analysis on its instruments, as well as 25-color immunoprofiling assay that provides turnkey solutions for identifying major human immune subpopulations for TBNK cells, monocytes, dendritic cells, and basophils. In addition, it offers automated micro-sampling system and automated sample loader system, an automated loaders to integrate seamlessly into the aurora and northern lights systems; SpectroFlo software that provides intuitive workflow from quality control to data analysis for aurora and northern lights systems; and customer support tools. The company serves pharmaceutical and biopharma companies, academic research centers, and clinical research organizations. It distributes its products through direct sales force and support organizations in North America, Europe, China, and the Asia-Pacific regions; and through distributors or sales agents in European, Latin American, and the Middle Eastern countries. The company was formerly known as Cytoville, Inc. and changed its name to Cytek Biosciences, Inc. in August 2015. Cytek Biosciences, Inc. was founded in 1992 and is headquartered in Fremont, California.
help-icon Live chat